In The News Banner

Effects of infant formula with Human Milk Oligosaccharides on growth and morbidity: A Randomized Multicenter Trial

Author: Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, Wernimont S, Egli D, Gosoniu J and Steenhout P | Journal: Journal of Pediatric Gastroenterology and Nutrition

Volume: 64
Issue: 4
DOI: 10.1097/MPG.0000000000001520

Objectives:The aim of the study was to evaluate the effects of infant formula supplemented with 2 human milk oligosaccharides (HMOs) on infant growth, tolerance, and morbidity.

Methods:Healthy infants, 0 to 14 days old, were randomized to an intact protein, cow’s milk–based infant formula (control, n=87) or the same formula with 1.0 g/L 2’fucosyllactose (2’FL) and 0.5 g/L lacto-N-neotetraose (LNnT) (test, n=88) from enrollment to 6 months; all infants received standard follow-up formula without HMOs from 6 to 12 months. Primary endpoint was weight gain through 4 months. Secondary endpoints included additional anthropometric measures, gastrointestinal tolerance, behavioral patterns, and morbidity through age 12 months.

Results:Weight gain was similar in both groups (mean difference [95% confidence interval] test vs control: –0.30 [–1.94, 1.34] g/day; lower bound of 95% confidence interval was above noninferiority margin [–3 g/day]). Digestive symptoms and behavioral patterns were similar between groups; exceptions included softer stool (P=0.021) and fewer nighttime wake-ups (P=0.036) in the test group at 2 months. Infants receiving test (vs control) had significantly fewer parental reports (P=0.004–0.047) of bronchitis through 4 (2.3% vs 12.6%), 6 (6.8% vs 21.8%), and 12 months (10.2% vs 27.6%); lower respiratory tract infection (adverse event cluster) through 12months (19.3% vs 34.5%); antipyretics use through 4 months (15.9% vs 29.9%); and antibiotics use through 6 (34.1% vs 49.4%) and 12 months (42.0% vs 60.9%).

Conclusions: Infant formula with 2’FL and LNnT is safe, well-tolerated, and supports age-appropriate growth. Secondary outcome findings showing associations between consuming HMO-supplemented formula and lower parent-reported morbidity (particularly bronchitis) and medication use (antipyretics and antibiotics) warrant confirmation in future studies Read More

*Clicking here will redirect you to a third party website.

Comments |0


Related Topics


Please rotate your device

We don't support landscape mode. Please go back to portrait mode for the best experience.

scroll to top